BenzingaOctober 12, 2026 at 5:10 AM NY15 Days Ago
Citizens Maintains Market Outperform on AMERISAFE, Lowers Price Target to $40
Citizens analyst Matthew Carletti maintains AMERISAFE (NASDAQ:AMSF) with a Market Outperform and lowers the price target from $42 to $40.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
